Darnitsa Pharmaceutical Company entered the markets of six new countries in 2024: the EU, Bosnia and Herzegovina, Israel, New Zealand, Malaysia and registered 10 new medicines abroad. These medicines are used to treat heart and kidney failure, liver diseases, arterial hypertension, as well as to combat infections of the oral cavity and throat.
Source: https://mind.ua/news/20284258-darnicya-vijshla-na-shist-novih-rinkiv-u-2024-roci
